Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
filingDate |
2015-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2018-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2018-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-106470992-B |
titleOfInvention |
Pyrido[1,2-A]pyrimidinone analogs as PI3K inhibitors |
abstract |
Disclosed is a class of pyrido[1,2-a]pyrimidinone analogues as PI3K inhibitors, specifically related to the compound represented by formula (I) or a pharmaceutically acceptable salt thereof. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108602815-A |
priorityDate |
2014-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |